Roche Diagnostics Urisys 1100 Urine Analyzer
Reagent, Occult Blood. 510(k) K033548, from Roche Diagnostics Corp. (Indianapolis, IN). Product code KHE, class 2.
As of Nov 18, 2026, K033548 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Nov 24, 2003 after 12 days, with 1 recall tied to it in FDA's recall database.
- Review time: 12 days
- Recalls: 1
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Urisys 1100 Urine Analyzer is a reflectance photometer designed to automatically read and evaluate the results of Chemstrip 5 OB, Chemstrip 7 and Chemstrip 10 MD urine test strips for various urine analytes: specific gravity, pH, leukocytes, nitrite, protein, glucose, ketones, urobilinogen, bilirubin and blood.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Chemstrip 101 Urine AnalyzerK983510 · Boehringer Mannheim Corp. · Oct 27, 1998
- Chemstrip 5 Ob, Chemstrip 7 and Chemstrip 10 MD Test StripsK032437 · Roche Diagnostics Corp. · Oct 8, 2003
Recalls
Recalls FDA ties to K033548, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record| Started | Recall | Status |
|---|---|---|
| Sep 24, 2018 | Z-0301-2019Limits of Detection (LoD) for protein, nitrite, leukocytes, and erythrocytes on the Urisys 1100 urine analyzer with Chemstrip 5 OB, Chemstrip 7, Chemstrip 10 MD, and Chemstrip 10 UA test strips were higher than what is… | Terminated |
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Nov 12, 2003
- Review panel
- Hematology
- Regulation
- 21 CFR 864.6550
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files